FDA approval for latest generation of Boston Scientific devices.

The Pumping Marvellous Foundation
The Pumping Marvellous Foundation – the UK’s heart failure charity

Boston Scientific said it has received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance patient care.

The company said the newly approved devices include the DYNAGEN MINI and INOGEN MINI ICDs, as well as the DYNAGEN X4 and INOGEN X4 CRT-Ds. Boston Scientific has noted that the X4 line of quadripolar CRT-Ds offers 70% more pacing options to address high capture thresholds and phrenic nerve stimulation effectively, along with the largest battery capacity in the industry.

Extending the Boston Scientific portfolio of defibrillators, the ICDs in the MINI family are the world’s smallest and thinnest devices and are designed for patient comfort.

Enhanced by Zemanta